市場調查報告書

全身性紅斑性狼瘡治療市場(藥物:抗瘧疾藥,非類固醇抗發炎性藥,皮質類固醇,免疫抑制劑:全球產業分析,規模,佔有率,成長,趨勢,預測(2019∼2027年)

Systemic Lupus Erythematosus Treatment Market (Drug: Antimalarial Drugs, Non-steroidal Anti-inflammatory Drugs, Corticosteroids, Immunosuppressive Drugs - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

出版商 Transparency Market Research 商品編碼 920613
出版日期 內容資訊 英文 211 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全身性紅斑性狼瘡治療市場(藥物:抗瘧疾藥,非類固醇抗發炎性藥,皮質類固醇,免疫抑制劑:全球產業分析,規模,佔有率,成長,趨勢,預測(2019∼2027年) Systemic Lupus Erythematosus Treatment Market (Drug: Antimalarial Drugs, Non-steroidal Anti-inflammatory Drugs, Corticosteroids, Immunosuppressive Drugs - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027
出版日期: 2019年10月29日內容資訊: 英文 211 Pages
簡介

本報告提供全身性紅斑性狼瘡治療市場相關調查,彙整市場趨勢與預測,市場規模,主要加入企業,各地區趨勢相關資訊。

第1章 序論

第2章 假設和調查方法

第3章 摘要整理

第4章 市場概要

  • 產品概要
  • 主要的產業活動
  • 市場趨勢
    • 促進要素
    • 阻礙要素
    • 機會
  • 市場收益預測
  • 市場預測

第5章 市場預測

  • 主要的合併·收購
  • 開發平台分析
  • 全球主要國家的疾病罹患率與發病率

第6章 市場分析:各藥物

  • 簡介
  • 市場值佔有率與魅力度分析
  • 市場預測
    • 抗瘧疾藥
    • 非類固醇抗發炎性藥
    • 皮質類固醇
    • 免疫抑制劑
    • 其他

第7章 市場分析:各投藥法

  • 簡介
  • 市場值佔有率與魅力度分析
  • 市場預測
    • 血管內
    • 皮下
    • 口服
  • 市場分析

第8章 市場分析:各流通管道

  • 簡介
  • 市場值佔有率與魅力度分析
  • 市場預測
    • 院內藥局
    • 零售藥局
    • 線上藥局
  • 市場分析

第9章 市場分析:各地區

  • 市場方案
  • 市場值佔有率與魅力度分析
  • 市場預測
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲

第10章 北美

第11章 歐洲

第12章 亞太地區

第13章 南美

第14章 中東·非洲

第15章 競爭環境

  • 競爭矩陣
  • 企業簡介
目錄

Systemic Lupus Erythematosus Treatment Market - Scope of the Report

TMR's report on the global systemic lupus erythematosus treatment market studies the past as well as current growth trends and opportunities, to gain valuable insights of the indicators for the said market for the forecast period of 2019 to 2027. The report provides the overall market revenue of the global systemic lupus erythematosus treatment market for the period of 2017-2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global systemic lupus erythematosus treatment market from 2019 to 2027.

The report is prepared after extensive research. Primary research involved bulk of the research efforts, wherein, analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Extensive secondary research involved reaching out to key players' product literature, annual reports, press releases, and relevant documents to understand the systemic lupus erythematosus treatment market.

Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of the top-down and bottom-up approach to study the various attributes of the systemic lupus erythematosus treatment market.

The report includes an elaborate executive summary along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global systemic lupus erythematosus treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global systemic lupus erythematosus treatment market.

The report delves into the competitive landscape of the global systemic lupus erythematosus treatment market. Key players operating in the global systemic lupus erythematosus treatment market are identified and each one of them is profiled in terms of various attributes. Company overviews, financial standings, recent developments, and SWOT are the attributes of players in the global systemic lupus erythematosus treatment market that are profiled in this report.

Key Questions Answered in the Systemic Lupus Erythematosus Treatment Market Report

What is the sales/revenue expected to be generated by systemic lupus erythematosus treatment across all regions during the forecast period?

What are the opportunities in the systemic lupus erythematosus treatment market?

What are the major drivers, restraints, opportunities, and threats in the market?

Which region is set to expand at the fastest CAGR during the forecast period?

Which product segment is expected to generate the highest revenue, globally, in 2027? Which segment is projected to expand at the highest CAGR during the forecast period?

What are the market positions of different companies operating in the global market?

Research Objectives and Research Approach

The comprehensive report on the global systemic lupus erythematosus treatment market begins with an overview, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives behind this study, key vendors and distributors operating in the market, and regulatory scenario for the approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to the readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period

Table of Contents

1. Preface

  • 1.1. Report Scope and Market Segmentation
  • 1.2. Research Highlights

2. Assumptions and Research Methodology

  • 2.1. Assumptions
  • 2.2. Research Methodology

3. Executive Summary

  • 3.1. Global Systemic Lupus Erythematosus Treatment Market Snapshot

4. Market Overview

  • 4.1. Product Overview
  • 4.2. Key Industry Events
  • 4.3. Market Dynamics
    • 4.3.1. Drivers and Restraints Snapshot Analysis
    • 4.3.2. Drivers
    • 4.3.3. Restraints
    • 4.3.4. Opportunities
  • 4.4. Global Systemic Lupus Erythematosus Treatment Market Revenue Projection
  • 4.5. Global Systemic Lupus Erythematosus Treatment Market Outlook

5. Market Outlook

  • 5.1. Key Mergers & Acquisitions
  • 5.2. Pipeline Analysis
  • 5.3. Disease Prevalence & Incidence Rate Globally with Key Countries

6. Global Systemic Lupus Erythematosus Treatment Market Analysis, by Drug

  • 6.1. Introduction
  • 6.2. Global Systemic Lupus Erythematosus Treatment Market Value Share and Attractiveness Analysis, by Drug
  • 6.3. Global Systemic Lupus Erythematosus Treatment Market Forecast, by Drug
    • 6.3.1. Antimalarial Drugs
      • 6.3.1.1. Chloroquine
      • 6.3.1.2. Hydrochloroquine
    • 6.3.2. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
      • 6.3.2.1. Ibuprofen
      • 6.3.2.2. Naproxen
      • 6.3.2.3. Others
    • 6.3.3. Corticosteroids
      • 6.3.3.1. Prednisone
      • 6.3.3.2. Hydrocortisone
      • 6.3.3.3. Dexamethasone
      • 6.3.3.4. Others
    • 6.3.4. Immunosuppressive Drugs
      • 6.3.4.1. Azathioprine
      • 6.3.4.2. Cyclophosphamide
      • 6.3.4.3. Methotrexate
      • 6.3.4.4. Others
    • 6.3.5. Others (Biologics, B-cell Modulators, etc.)

7. Global Systemic Lupus Erythematosus Treatment Market Analysis, by Mode of Delivery

  • 7.1. Introduction
  • 7.2. Global Systemic Lupus Erythematosus Treatment Market Value Share and Attractiveness Analysis, by Mode of Delivery
  • 7.3. Global Systemic Lupus Erythematosus Treatment Market Forecast, by Mode of Delivery
    • 7.3.1. Intravenous
    • 7.3.2. Subcutaneous
    • 7.3.3. Oral
  • 7.4. Global Systemic Lupus Erythematosus Treatment Market Analysis, by Mode of Delivery

8. Global Systemic Lupus Erythematosus Treatment Market Analysis, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Global Systemic Lupus Erythematosus Treatment Market Value Share and Attractiveness Analysis, by Distribution Channel
  • 8.3. Global Systemic Lupus Erythematosus Treatment Market Forecast, by Distribution Channel
    • 8.3.1. Hospital Pharmacies
    • 8.3.2. Retail Pharmacies
    • 8.3.3. Online Sales
  • 8.4. Global Systemic Lupus Erythematosus Treatment Market Analysis, by Distribution Channel

9. Global Systemic Lupus Erythematosus Treatment Market Analysis, by Region

  • 9.1. Global Systemic Lupus Erythematosus Treatment Market Scenario, by Country
  • 9.2. Global Systemic Lupus Erythematosus Treatment Market Value Share and Attractiveness Analysis, by Region
  • 9.3. Global Systemic Lupus Erythematosus Treatment Market Forecast, by Region
    • 9.3.1. North America
    • 9.3.2. Europe
    • 9.3.3. Asia Pacific
    • 9.3.4. Latin America
    • 9.3.5. Middle East & Africa

10. North America Systemic Lupus Erythematosus Treatment Market Analysis

  • 10.1. Key Findings
  • 10.2. North America Systemic Lupus Erythematosus Treatment Market Overview
  • 10.3. North America Systemic Lupus Erythematosus Treatment Market Value Share and Attractiveness Analysis, by Country
  • 10.4. North America Systemic Lupus Erythematosus Treatment Market Forecast, by Country
    • 10.4.1. U.S.
    • 10.4.2. Canada
  • 10.5. North America Systemic Lupus Erythematosus Treatment Market Value Share and Attractiveness Analysis, by Drug
  • 10.6. North America Systemic Lupus Erythematosus Treatment Market Forecast, by Drug
    • 10.6.1. Antimalarial Drugs
      • 10.6.1.1. Chloroquine
      • 10.6.1.2. Hydrochloroquine
    • 10.6.2. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
      • 10.6.2.1. Ibuprofen
      • 10.6.2.2. Naproxen
      • 10.6.2.3. Others
    • 10.6.3. Corticosteroids
      • 10.6.3.1. Prednisone
      • 10.6.3.2. Hydrocortisone
      • 10.6.3.3. Dexamethasone
      • 10.6.3.4. Others
    • 10.6.4. Immunosuppressive Drugs
      • 10.6.4.1. Azathioprine
      • 10.6.4.2. Cyclophosphamide
      • 10.6.4.3. Methotrexate
      • 10.6.4.4. Others
    • 10.6.5. Others (Biologics, B-cell Modulators, etc.)
  • 10.7. North America Systemic Lupus Erythematosus Treatment Market Value Share Analysis, by Mode of Delivery
  • 10.8. North America Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Mode of Delivery
    • 10.8.1. Intravenous
    • 10.8.2. Subcutaneous
    • 10.8.3. Oral
  • 10.9. North America Systemic Lupus Erythematosus Treatment Market Value Share and Attractiveness Analysis, by Distribution Channel
  • 10.10. North America Systemic Lupus Erythematosus Treatment Market Forecast, by Distribution Channel
    • 10.10.1. Hospital Pharmacies
    • 10.10.2. Retail Pharmacies
    • 10.10.3. Online Sales

11. Europe Systemic Lupus Erythematosus Treatment Market Analysis

  • 11.1. Key Findings
  • 11.2. Europe Systemic Lupus Erythematosus Treatment Market Overview
  • 11.3. Europe Systemic Lupus Erythematosus Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
  • 11.4. Europe Systemic Lupus Erythematosus Treatment Market Forecast, by Country/Sub-region
    • 11.4.1. Germany
    • 11.4.2. U.K.
    • 11.4.3. France
    • 11.4.4. Spain
    • 11.4.5. Italy
    • 11.4.6. Rest of Europe
  • 11.5. Europe Systemic Lupus Erythematosus Treatment Market Value Share and Attractiveness Analysis, by Drug
  • 11.6. Europe Systemic Lupus Erythematosus Treatment Market Forecast, by Drug
    • 11.6.1. Antimalarial Drugs
      • 11.6.1.1. Chloroquine
      • 11.6.1.2. Hydrochloroquine
    • 11.6.2. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
      • 11.6.2.1. Ibuprofen
      • 11.6.2.2. Naproxen
      • 11.6.2.3. Others
    • 11.6.3. Corticosteroids
      • 11.6.3.1. Prednisone
      • 11.6.3.2. Hydrocortisone
      • 11.6.3.3. Dexamethasone
      • 11.6.3.4. Others
    • 11.6.4. Immunosuppressive Drugs
      • 11.6.4.1. Azathioprine
      • 11.6.4.2. Cyclophosphamide
      • 11.6.4.3. Methotrexate
      • 11.6.4.4. Others
    • 11.6.5. Others (Biologics, B-cell Modulators, etc.)
  • 11.7. Europe Systemic Lupus Erythematosus Treatment Market Value Share Analysis, by Mode of Delivery
  • 11.8. Europe Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Mode of Delivery
    • 11.8.1. Intravenous
    • 11.8.2. Subcutaneous
    • 11.8.3. Oral
  • 11.9. Europe Systemic Lupus Erythematosus Treatment Market Value Share and Attractiveness Analysis, by Distribution Channel
  • 11.10. Europe Systemic Lupus Erythematosus Treatment Market Forecast, by Distribution Channel
    • 11.10.1. Hospital Pharmacies
    • 11.10.2. Retail Pharmacies
    • 11.10.3. Online Sales

12. Asia Pacific Systemic Lupus Erythematosus Treatment Market Analysis

  • 12.1. Key Findings
  • 12.2. Asia Pacific Systemic Lupus Erythematosus Treatment Market Overview
  • 12.3. Asia Pacific Systemic Lupus Erythematosus Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
  • 12.4. Asia Pacific Systemic Lupus Erythematosus Treatment Market Forecast, by Country/Sub-region
    • 12.4.1. Japan
    • 12.4.2. China
    • 12.4.3. India
    • 12.4.4. Australia & New Zealand
    • 12.4.5. Rest of Asia Pacific
  • 12.5. Asia Pacific Systemic Lupus Erythematosus Treatment Market Value Share and Attractiveness Analysis, by Drug
  • 12.6. Asia Pacific Systemic Lupus Erythematosus Treatment Market Forecast, by Drug
    • 12.6.1. Antimalarial Drugs
      • 12.6.1.1. Chloroquine
      • 12.6.1.2. Hydrochloroquine
    • 12.6.2. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
      • 12.6.2.1. Ibuprofen
      • 12.6.2.2. Naproxen
      • 12.6.2.3. Others
    • 12.6.3. Corticosteroids
      • 12.6.3.1. Prednisone
      • 12.6.3.2. Hydrocortisone
      • 12.6.3.3. Dexamethasone
      • 12.6.3.4. Others
    • 12.6.4. Immunosuppressive Drugs
      • 12.6.4.1. Azathioprine
      • 12.6.4.2. Cyclophosphamide
      • 12.6.4.3. Methotrexate
      • 12.6.4.4. Others
    • 12.6.5. Others (Biologics, B-cell Modulators, etc.)
  • 12.7. Asia Pacific Systemic Lupus Erythematosus Treatment Market Value Share Analysis, by Mode of Delivery
  • 12.8. Asia Pacific Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Mode of Delivery
    • 12.8.1. Intravenous
    • 12.8.2. Subcutaneous
    • 12.8.3. Oral
  • 12.9. Asia Pacific Systemic Lupus Erythematosus Treatment Market Value Share and Attractiveness Analysis, by Distribution Channel
  • 12.10. Asia Pacific Systemic Lupus Erythematosus Treatment Market Forecast, by Distribution Channel
    • 12.10.1. Hospital Pharmacies
    • 12.10.2. Retail Pharmacies
    • 12.10.3. Online Sales

13. Latin America Systemic Lupus Erythematosus Treatment Market Analysis

  • 13.1. Key Findings
  • 13.2. Latin America Systemic Lupus Erythematosus Treatment Market Overview
  • 13.3. Latin America Systemic Lupus Erythematosus Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
  • 13.4. Latin America Systemic Lupus Erythematosus Treatment Market Forecast, by Country/Sub-region
    • 13.4.1. Brazil
    • 13.4.2. Mexico
    • 13.4.3. Rest of Latin America
  • 13.5. Latin America Systemic Lupus Erythematosus Treatment Market Value Share and Attractiveness Analysis, by Drug
  • 13.6. Latin America Systemic Lupus Erythematosus Treatment Market Forecast, by Drug
    • 13.6.1. Antimalarial Drugs
      • 13.6.1.1. Chloroquine
      • 13.6.1.2. Hydrochloroquine
    • 13.6.2. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
      • 13.6.2.1. Ibuprofen
      • 13.6.2.2. Naproxen
      • 13.6.2.3. Others
    • 13.6.3. Corticosteroids
      • 13.6.3.1. Prednisone
      • 13.6.3.2. Hydrocortisone
      • 13.6.3.3. Dexamethasone
      • 13.6.3.4. Others
    • 13.6.4. Immunosuppressive Drugs
      • 13.6.4.1. Azathioprine
      • 13.6.4.2. Cyclophosphamide
      • 13.6.4.3. Methotrexate
      • 13.6.4.4. Others
    • 13.6.5. Others (Biologics, B-cell Modulators, etc.)
  • 13.7. Latin America Systemic Lupus Erythematosus Treatment Market Value Share Analysis, by Mode of Delivery
  • 13.8. Latin America Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Mode of Delivery
    • 13.8.1. Intravenous
    • 13.8.2. Subcutaneous
    • 13.8.3. Oral
  • 13.9. Latin America Systemic Lupus Erythematosus Treatment Market Value Share and Attractiveness Analysis, by Distribution Channel
  • 13.10. Latin America Systemic Lupus Erythematosus Treatment Market Forecast, by Distribution Channel
    • 13.10.1. Hospital Pharmacies
    • 13.10.2. Retail Pharmacies
    • 13.10.3. Online Sales

14. Middle East & Africa Systemic Lupus Erythematosus Treatment Market Analysis

  • 14.1. Key Findings
  • 14.2. Middle East & Africa Systemic Lupus Erythematosus Treatment Market Overview
  • 14.3. Middle East & Africa Systemic Lupus Erythematosus Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
  • 14.4. Middle East & Africa Systemic Lupus Erythematosus Treatment Market Forecast, by Country/Sub-region
    • 14.4.1. GCC Countries
    • 14.4.2. South Africa
    • 14.4.3. Rest of Middle East & Africa
  • 14.5. Middle East & Africa Systemic Lupus Erythematosus Treatment Market Value Share and Attractiveness Analysis, by Drug
  • 14.6. Middle East & Africa Systemic Lupus Erythematosus Treatment Market Forecast, by Drug
    • 14.6.1. Antimalarial Drugs
      • 14.6.1.1. Chloroquine
      • 14.6.1.2. Hydrochloroquine
    • 14.6.2. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
      • 14.6.2.1. Ibuprofen
      • 14.6.2.2. Naproxen
      • 14.6.2.3. Others
    • 14.6.3. Corticosteroids
      • 14.6.3.1. Prednisone
      • 14.6.3.2. Hydrocortisone
      • 14.6.3.3. Dexamethasone
      • 14.6.3.4. Others
    • 14.6.4. Immunosuppressive Drugs
      • 14.6.4.1. Azathioprine
      • 14.6.4.2. Cyclophosphamide
      • 14.6.4.3. Methotrexate
      • 14.6.4.4. Others
    • 14.6.5. Others (Biologics, B-cell Modulators, etc.)
  • 14.7. Middle East & Africa Systemic Lupus Erythematosus Treatment Market Value Share Analysis, by Mode of Delivery
  • 14.8. Middle East & Africa Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Mode of Delivery
    • 14.8.1. Intravenous
    • 14.8.2. Subcutaneous
    • 14.8.3. Oral
  • 14.9. Middle East & Africa Systemic Lupus Erythematosus Treatment Market Value Share and Attractiveness Analysis, by Distribution Channel
  • 14.10. Middle East & Africa Systemic Lupus Erythematosus Treatment Market Forecast, by Distribution Channel
    • 14.10.1. Hospital Pharmacies
    • 14.10.2. Retail Pharmacies
    • 14.10.3. Online Sales

15. Competitive Landscape

  • 15.1. Competition Matrix
  • 15.2. Company Profile
    • 15.2.1. GlaxoSmithKline plc
      • 15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.1.2. Financial Overview
      • 15.2.1.3. Product Portfolio
      • 15.2.1.4. SWOT Analysis
      • 15.2.1.5. Strategic Overview
    • 15.2.2. F. Hoffmann-La Roche Ltd.
      • 15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.2.2. Financial Overview
      • 15.2.2.3. Product Portfolio
      • 15.2.2.4. SWOT Analysis
      • 15.2.2.5. Strategic Overview
    • 15.2.3. Pfizer, Inc.
      • 15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.3.2. Financial Overview
      • 15.2.3.3. Product Portfolio
      • 15.2.3.4. SWOT Analysis
      • 15.2.3.5. Strategic Overview
    • 15.2.4. AstraZeneca plc
      • 15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.4.2. Financial Overview
      • 15.2.4.3. Product Portfolio
      • 15.2.4.4. SWOT Analysis
      • 15.2.4.5. Strategic Overview
    • 15.2.5. Merck & Co., Inc.
      • 15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.5.2. Financial Overview
      • 15.2.5.3. Product Portfolio
      • 15.2.5.4. SWOT Analysis
      • 15.2.5.5. Strategic Overview
    • 15.2.6. Bristol-Myers Squibb Company
      • 15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.6.2. Financial Overview
      • 15.2.6.3. Product Portfolio
      • 15.2.6.4. SWOT Analysis
      • 15.2.6.5. Strategic Overview
    • 15.2.7. Anthera Pharmaceuticals, Inc.
      • 15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.7.2. Financial Overview
      • 15.2.7.3. Product Portfolio
      • 15.2.7.4. SWOT Analysis
      • 15.2.7.5. Strategic Overview
    • 15.2.8. ImmuPharma PLC
      • 15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.8.2. Product Portfolio
      • 15.2.8.3. SWOT Analysis
      • 15.2.8.4. Strategic Overview
    • 15.2.9. Aurinia Pharmaceuticals, Inc.
      • 15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.9.2. Product Portfolio
      • 15.2.9.3. SWOT Analysis
      • 15.2.9.4. Strategic Overview

List of Tables

  • Table 01: Global Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Drug, 2017-2027
  • Table 02: Global Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Antimalarial Drugs, 2017-2027
  • Table 03: Global Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Non-steroidal Anti-inflammatory Drugs (NSAIDS), 2017-2027
  • Table 04: Global Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Corticosteroids, 2017-2027
  • Table 05: Global Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Immunosuppressive Drugs, 2017-2027
  • Table 06: Global Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Mode of Delivery, 2017-2027
  • Table 07: Global Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 08: Global Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Region, 2017-2027
  • Table 09: North America Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Country, 2017-2027
  • Table 10: North America Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Drug, 2017-2027
  • Table 11: North America Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Antimalarial Drugs, 2017-2027
  • Table 12: North America Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Non-steroidal Anti-inflammatory Drugs (NSAIDS), 2017-2027
  • Table 13: North America Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Corticosteroids, 2017-2027
  • Table 14: North America Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Immunosuppressive Drugs, 2017-2027
  • Table 15: North America Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Mode of Delivery, 2017-2027
  • Table 16: North America Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 17: Europe Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 18: Europe Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Drug, 2017-2027
  • Table 19: Europe Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Antimalarial Drugs, 2017-2027
  • Table 20: Europe Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Non-steroidal Anti-inflammatory Drugs (NSAIDS), 2017-2027
  • Table 21: Europe Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Corticosteroids, 2017-2027
  • Table 22: Europe Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Immunosuppressive Drugs, 2017-2027
  • Table 23: Europe Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Mode of Delivery, 2017-2027
  • Table 24: Europe Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 25: Asia Pacific Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 26: Asia Pacific Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Drug, 2017-2027
  • Table 27: Asia Pacific Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Antimalarial Drugs, 2017-2027
  • Table 28: Asia Pacific Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Non-steroidal Anti-inflammatory Drugs (NSAIDS), 2017-2027
  • Table 29: Asia Pacific Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Corticosteroids, 2017-2027
  • Table 30: Asia Pacific Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Immunosuppressive Drugs, 2017-2027
  • Table 31: Asia Pacific Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Mode of Delivery, 2017-2027
  • Table 32: Asia Pacific Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 33: Latin America Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 34: Latin America Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Drug, 2017-2027
  • Table 35: Latin America Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Antimalarial Drugs, 2017-2027
  • Table 36: Latin America Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Non-steroidal Anti-inflammatory Drugs (NSAIDS), 2017-2027
  • Table 37: Latin America Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Corticosteroids, 2017-2027
  • Table 38: Latin America Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Immunosuppressive Drugs, 2017-2027
  • Table 39: Latin America Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Mode of Delivery, 2017-2027
  • Table 40: Latin America Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 41: Middle East & Africa Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 42: Middle East & Africa Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Drug, 2017-2027
  • Table 43: Middle East & Africa Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Antimalarial Drugs, 2017-2027
  • Table 44: Middle East & Africa Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Non-steroidal Anti-inflammatory Drugs (NSAIDS), 2017-2027
  • Table 45: Middle East & Africa Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Corticosteroids, 2017-2027
  • Table 46: Middle East & Africa Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Immunosuppressive Drugs, 2017-2027
  • Table 47: Middle East & Africa Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Mode of Delivery, 2017-2027
  • Table 48: Middle East & Africa Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027

List of Figures

  • Figure 01: Global Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) and Distribution (%), by Region, 2018 and 2027
  • Figure 02: Global Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) and Forecast, 2019-2027
  • Figure 03: Global Systemic Lupus Erythematosus Treatment Market Value Share (%), by Drug, 2018
  • Figure 04: Global Systemic Lupus Erythematosus Treatment Market Value Share (%), by Mode of Delivery, 2018
  • Figure 05: Global Systemic Lupus Erythematosus Treatment Market Value Share (%), by Distribution Channel, 2018
  • Figure 06: Global Systemic Lupus Erythematosus Treatment Market Value Share (%), by Region, 2018
  • Figure 07: Global Systemic Lupus Erythematosus Treatment Market Value Share Analysis, by Drug, 2018 and 2027
  • Figure 08: Global Systemic Lupus Erythematosus Treatment Market Attractiveness, by Drug, 2019-2027
  • Figure 09: Global Systemic Lupus Erythematosus Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Antimalarial Drugs, 2017-2027
  • Figure 10: Global Systemic Lupus Erythematosus Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Non-steroidal Anti-inflammatory Drugs (NSAIDS), 2017-2027
  • Figure 11: Global Systemic Lupus Erythematosus Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Corticosteroids, 2017-2027
  • Figure 12: Global Systemic Lupus Erythematosus Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Immunosuppressive Drugs, 2017-2027
  • Figure 13: Global Systemic Lupus Erythematosus Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others (Biologics, B-cell Modulators, etc.), 2017-2027
  • Figure 14: Global Systemic Lupus Erythematosus Treatment Market Value Share Analysis, by Mode of Delivery, 2018 and 2027
  • Figure 15: Global Systemic Lupus Erythematosus Treatment Market Attractiveness, by Mode of Delivery, 2019-2027
  • Figure 16: Global Systemic Lupus Erythematosus Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Intravenous, 2017-2027
  • Figure 17: Global Systemic Lupus Erythematosus Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Subcutoneous, 2017-2027
  • Figure 18: Global Systemic Lupus Erythematosus Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Oral, 2017-2027
  • Figure 19: Global Systemic Lupus Erythematosus Treatment Market Value Share, by Distribution Channel, 2018 and 2027
  • Figure 20: Global Systemic Lupus Erythematosus Treatment Market Attractiveness, by Distribution Channel, 2019-2027
  • Figure 21: Global Systemic Lupus Erythematosus Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2017-2027
  • Figure 22: Global Systemic Lupus Erythematosus Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2017-2027
  • Figure 23: Global Systemic Lupus Erythematosus Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Online Sales, 2017-2027
  • Figure 24: Global Systemic Lupus Erythematosus Treatment Market Value Share, by Region, 2018 and 2027
  • Figure 25: Global Systemic Lupus Erythematosus Treatment Market Attractiveness, by Region, 2019-2027
  • Figure 26: North America Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 27: North America Systemic Lupus Erythematosus Treatment Market Value Share Analysis, by Country, 2018 and 2027
  • Figure 28: North America Systemic Lupus Erythematosus Treatment Market Attractiveness, by Country, 2019-2027
  • Figure 29: North America Systemic Lupus Erythematosus Treatment Market Value Share Analysis, by Drug, 2018 and 2027
  • Figure 30: North America Systemic Lupus Erythematosus Treatment Market Attractiveness, by Drug, 2019-2027
  • Figure 31: North America Systemic Lupus Erythematosus Treatment Market Value Share Analysis, by Mode of Delivery, 2018 and 2027
  • Figure 32: North America Systemic Lupus Erythematosus Treatment Market Attractiveness, by Mode of Delivery, 2019-2027
  • Figure 33: North America Systemic Lupus Erythematosus Treatment Market Value Share, by Distribution Channel, 2018 and 2027
  • Figure 34: North America Systemic Lupus Erythematosus Treatment Market Attractiveness, by Distribution Channel, 2019-2027
  • Figure 35: Europe Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 36: Europe Systemic Lupus Erythematosus Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 37: Europe Systemic Lupus Erythematosus Treatment Market Attractiveness, by Country/Sub-region, 2019-2027
  • Figure 38: Europe Systemic Lupus Erythematosus Treatment Market Value Share Analysis, by Drug, 2018 and 2027
  • Figure 39: Europe Systemic Lupus Erythematosus Treatment Market Attractiveness, by Drug, 2019-2027
  • Figure 40: Europe Systemic Lupus Erythematosus Treatment Market Value Share Analysis, by Mode of Delivery, 2018 and 2027
  • Figure 41: Europe Systemic Lupus Erythematosus Treatment Market Attractiveness, by Mode of Delivery, 2019-2027
  • Figure 42: Europe Systemic Lupus Erythematosus Treatment Market Value Share, by Distribution Channel, 2018 and 2027
  • Figure 43: Europe Systemic Lupus Erythematosus Treatment Market Attractiveness, by Distribution Channel, 2019-2027
  • Figure 44: Asia Pacific Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 45: Asia Pacific Systemic Lupus Erythematosus Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 46: Asia Pacific Systemic Lupus Erythematosus Treatment Market Attractiveness, by Country/Sub-region, 2019-2027
  • Figure 47: Asia Pacific Systemic Lupus Erythematosus Treatment Market Value Share Analysis, by Drug, 2018 and 2027
  • Figure 48: Asia Pacific Systemic Lupus Erythematosus Treatment Market Attractiveness, by Drug, 2019-2027
  • Figure 49: Asia Pacific Systemic Lupus Erythematosus Treatment Market Value Share Analysis, by Mode of Delivery, 2018 and 2027
  • Figure 50: Asia Pacific Systemic Lupus Erythematosus Treatment Market Attractiveness, by Mode of Delivery, 2019-2027
  • Figure 51: Asia Pacific Systemic Lupus Erythematosus Treatment Market Value Share, by Distribution Channel, 2018 and 2027
  • Figure 52: Asia Pacific Systemic Lupus Erythematosus Treatment Market Attractiveness, by Distribution Channel, 2019-2027
  • Figure 53: Latin America Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 54: Latin America Systemic Lupus Erythematosus Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 55: Latin America Systemic Lupus Erythematosus Treatment Market Attractiveness, by Country/Sub-region, 2019-2027
  • Figure 56: Latin America Systemic Lupus Erythematosus Treatment Market Value Share Analysis, by Drug, 2018 and 2027
  • Figure 57: Latin America Systemic Lupus Erythematosus Treatment Market Attractiveness, by Drug, 2019-2027
  • Figure 58: Latin America Systemic Lupus Erythematosus Treatment Market Value Share Analysis, by Mode of Delivery, 2018 and 2027
  • Figure 59: Latin America Systemic Lupus Erythematosus Treatment Market Attractiveness, by Mode of Delivery, 2019-2027
  • Figure 60: Latin America Systemic Lupus Erythematosus Treatment Market Value Share, by Distribution Channel, 2018 and 2027
  • Figure 61: Latin America Systemic Lupus Erythematosus Treatment Market Attractiveness, by Distribution Channel, 2019-2027
  • Figure 62: Middle East & Africa Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 63: Middle East & Africa Systemic Lupus Erythematosus Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 64: Middle East & Africa Systemic Lupus Erythematosus Treatment Market Attractiveness, by Country/Sub-region, 2019-2027
  • Figure 65: Middle East & Africa Systemic Lupus Erythematosus Treatment Market Value Share Analysis, by Drug, 2018 and 2027
  • Figure 66: Middle East & Africa Systemic Lupus Erythematosus Treatment Market Attractiveness, by Drug, 2019-2027
  • Figure 67: Middle East & Africa Systemic Lupus Erythematosus Treatment Market Value Share Analysis, by Mode of Delivery, 2018 and 2027
  • Figure 68: Middle East & Africa Systemic Lupus Erythematosus Treatment Market Attractiveness, by Mode of Delivery, 2019-2027
  • Figure 69: Middle East & Africa Systemic Lupus Erythematosus Treatment Market Value Share, by Distribution Channel, 2018 and 2027
  • Figure 70: Middle East & Africa Systemic Lupus Erythematosus Treatment Market Attractiveness, by Distribution Channel, 2019-2027
Back to Top